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The inﬂuence of the gut microbiota on brain chemistry has been convincingly demonstrated in rodents. In
the absence of gut bacteria, the central expression of brain derived neurotropic factor, (BDNF), and
N-methyl-D-aspartate receptor (NMDAR) subunits are reduced, whereas, oral probiotics increase brain
BDNF, and impart signiﬁcant anxiolytic effects. We tested whether prebiotic compounds, which increase
intrinsic enteric microbiota, also affected brain BDNF and NMDARs. In addition, we examined whether
plasma from prebiotic treated rats released BDNF from human SH-SY5Y neuroblastoma cells, to provide
an initial indication of mechanism of action.
Rats were gavaged with fructo-oligosaccharides (FOS), galacto-oligosaccharides (GOS) or water for ﬁve
weeks, prior to measurements of brain BDNF, NMDAR subunits and amino acids associated with gluta-
mate neurotransmission (glutamate, glutamine, and serine and alanine enantiomers). Prebiotics
increased hippocampal BDNF and NR1 subunit expression relative to controls. The intake of GOS also
increased hippocampal NR2A subunits, and frontal cortex NR1 and D-serine. Prebiotics did not alter glu-
tamate, glutamine, L-serine, L-alanine or D-alanine concentrations in the brain, though GOSfeeding raised
plasma D-alanine. Elevated levels of plasma peptide YY (PYY) after GOS intake was observed. Plasma from
GOS rats increased the release of BDNF from SH-SY5Y cells, but not in the presence of PYY antisera. The
addition of synthetic PYY to SH-SY5Y cell cultures, also elevated BDNF secretion.
We conclude that prebiotic-mediated proliferation of gut microbiota in rats, like probiotics, increases
brain BDNF expression, possibly through the involvement of gut hormones. The effect of GOS on compo-
nents of central NMDAR signalling was greater than FOS, and may reﬂect the proliferative potency of GOS
on microbiota. Our data therefore, provide a sound basis to further investigate the utility of prebiotics in
the maintenance of brain health and adjunctive treatment of neuropsychiatric disorders.
 2013 The Authors. Published by Elsevier Ltd. Open access under CC BY license.1. Introduction
There is now compelling evidence for a link between the enteric
microbiota and brain function. The proliferation of the Biﬁdobacte-
ria and Lactobacilli strains in the large intestine, have anxiolytic and
mnemonic effects in both rodents (Li et al., 2009; Bravo et al.,
2011) and humans (Messaoudi et al., 2011a,b; Rao et al., 2009;
Cryan and Dinan, 2012). The intake of these bacteria as livecultures (probiotics) alters the expression of genes integral to neu-
rodevelopment and complex behaviours in rodents. For instance,
the oral administration of Biﬁdobacteria to rats elevated hippocam-
pal brain-derived neurotrophic factor (BDNF) (Bercik et al., 2011a;
O’Sullivan et al., 2011), which may underlie some antidepressant
actions (Kerman, 2012). At present, only several probiotics have
been examined, but it seems likely that of the 40,000 species in
the gut (Forsythe and Kunze, 2012), there will be others with psy-
chotropic properties. Thus, intuitively, augmenting the growth of
intrinsic gut microbiota with prebiotics (nutrients for intestinal
bacteria) may afford greater beneﬁts to the brain (Burnet, 2012).
The prebiotics, fructo-oligosaccharide, (FOS) and galacto-oligo-
saccharides, (GOS) are soluble ﬁbres which are digested by, and
result in the proliferation of, the Lactobacilli and Biﬁdobacteria in
the gut. Increasing the proportion of these bacteria with prebiotics
has many beneﬁcial effects on the gut and the immune system
H.M. Savignac et al. / Neurochemistry International 63 (2013) 756–764 757(Drakoularakou et al., 2010; van Vlies et al., 2012; Vulevic et al.,
2008, 2013), and increase circulating gut peptides such as gluca-
gon-like peptide-1 (GLP-1) and peptide YY (PYY), which beneﬁt
metabolism (Delmee et al., 2006; Overduin et al., 2013). However,
the central effects of prebiotic administration have not been
explored. Interestingly, selective antimicrobials which elevate the
levels of intrinsic gut Lactobacilli, also increase brain BDNF concen-
trations in mice (Bercik et al., 2011a). It is possible therefore, that
prebiotic-mediated microbiota proliferation has similar effects,
and the measurement of brain BDNF in rodents administered with
these compounds would provide the necessary proof-of-principle.
Additional evidence suggests that gut bacteria may also inﬂuence
glutamate neurotransmission in the brain.
Mice devoid of gut microbiota from birth have reduced levels of
N-methyl-D-aspartate receptors (NMDARs), speciﬁcally the NR1
and NR2A subunits, in the hippocampus (Sudo et al., 2004), or
NR2B subunits in the amygdala (Neufeld et al., 2011; Kiss et al.,
2012). To our knowledge, the effect of increasing gut microbiota
on brain NMDARs has not been explored, and such information
may have therapeutic relevance (Collingridge et al., 2013). Inter-
estingly, germ-free mice also lack circulating D-alanine, a bona ﬁde
NMDAR co-agonist which is rich in bacterial cell walls (Konno
et al., 1993), and their inoculation with bacteria restored D-alanine
concentrations, which were then increased further by an additional
administration of a Biﬁdobacteria. It is reasonable to propose, there-
fore, that an elevation of central D-alanine, and perhaps other ami-
no acids associated with glutamate neurotransmission, would
follow prebiotic administration, and thereby present as a strategy
to increase brain NMDAR signalling.
The three major aims of this study were to: (1) test if prebiotic
administration to rats altered brain levels of BDNF; (2) examine
whether central NMDARs and associated amino acids were altered
by prebiotics; and (3) provide initial evidence for neuroactive
blood-borne molecules that may affect central BDNF levels after
prebiotic feeding. We orally administered water, FOS or GOS to rats
for ﬁve weeks and measured BDNF NR1, NR2A and NR2B subunits
in the frontal cortex and hippocampus, and encoding mRNAs in the
hippocampus. The concentrations of glutamate, glutamine, and
serine and alanine enantiomers in the plasma, cortex and hippo-
campus were also quantiﬁed. Finally, we measured the levels of
PYY and GLP-1 in plasma from prebiotic-fed rats, and tested their
effect on BDNF release from SH-SY5Y neuroblastoma cells.2. Materials and methods
2.1. Animals
All rat experiments were carried out in accordance with UK
Home Ofﬁce guide lines and under approved licences. Adult male
Sprague Dawley rats (225–250 g) were obtained from Harlan Lab-
oratory, UK, and maintained under controlled 12-h light/dark cycle
(lights on 7:00 am), temperature (21 ± 1 C) and humidity
(55 ± 5%), with ad libitum access to drinking water/ﬂuid and food
(standard chow pellets). Rats were weighed at the start and end
of experiments.2.2. Prebiotic experiments
Rats were administered a daily oral administration (gavage) of
either water, FOS (3 g/kg) or GOS (4 g/kg), for 5 weeks (n = 8/
group). This dosing regimen was based on previous studies
(Anthony et al., 2006). Copies of Biﬁdobacteria spp. genes in DNA
extracted from faecal pellets were determined with standard QPCR
at the end of the study, as previously described (Ketabi et al., 2011).
Twenty-four hours after the last gavage, the animals weresacriﬁced, their brains removed and trunk blood collected in
EDTA-coated tubes. Blood was centrifuged (5000 rpm, 15 min) to
obtain plasma which was then stored at 80 C. The frontal cortex
and hippocampus were dissected out from half of the harvested
brains. Brain hemispheres and isolated regions were snap-frozen
in isopentane on dry-ice and stored with plasmas at 80 C prior
to use. Additional faecal pellets were collected from each animal
(n = 8/group), weighed, homogenised in PBS (1:1, w/v), and then
centrifuged at 14,000 rpm for 10 min at 4 C. Supernatants were re-
moved and stored at 80 C prior to HPLC analysis.
2.3. Glucose and gut hormone measurements
The concentration of blood glucose was measured in all plasma
samples using a GlucoMen LX, blood glucose meter (A. Menarini
Diagnostics, UK). Commercial ELISA kits were used to measure
plasma PYY (Abnova, UK) and GLP-1 (Millipore, UK), and were per-
formed according to manufacturer’s recommendations.
2.4. BDNF analysis
Cortex and hippocampus tissue from all groups (n = 8 rats/
group) were homogenised in RIPA buffer (1:10 w/v, Sigma–Aldrich,
UK) containing protease inhibitors (‘Complete-Mini’, Roche). Pro-
tein concentrations were determined using the Bradford reagent
(Sigma, UK). Samples of protein extracts were diluted 1:5 v/v in as-
say buffer, prior to their analysis with a commercial BDNF ELISA kit
(BDNF Emax immunoassay system, Promega, UK). Samples of cell
culture medium were ﬁrst diluted in an equal volume of RIPA,
and then further diluted (1:5) in BDNF assay buffer. The BDNF ELI-
SA was performed according to manufacturer’s recommendations.
2.5. Western blotting
Western blots were performed as previously described (Burnet
et al., 2011). Brieﬂy, equal concentrations of protein extracts of cor-
tex or hippocampus (20 lg) from prebiotic and control groups
(n = 8 rats/group) were mixed with loading buffer (50 mM 1,4-
dithiothreitol and 0.025% bromophenol blue), and fractionated
with a molecular weight marker (GE Healthcare, Buckinghamshire,
UK) by electrophoresis on pre-cast 7.5% SDS/polyacrylamide gels
(Biorad, UK), and trans-blotted onto polyvinyl diﬂuoride (PVDF)
membranes (Immobilon-P, Millipore, Watford, UK).
The membranes were blocked with 5% (w/v) non-fat milk in PBS
containing 0.1% Tween20 (PBST) for 45 min, and then incubated for
1 h at room temperature in incubation buffer (PBST with 2% [w/v]
milk) containing a primary antibody (diluted 1:1000) against one
of three NMDAR subunits: NR1 (AB9864, Millipore, UK), NR2A
(AB1555, Millipore, UK) and NR2B (AB15362, Millipore, UK), and
b-actin (Sigma–Aldrich, UK, diluted 1:50,000). Membranes were
then washed three times for ten minutes in PBST and incubated
for 30 min in HRP-linked secondary antibody in blocking buffer.
Immunoreactive bands were visualized by chemiluminescence
using the ECL-Plus kit (GE Healthcare, Buckinghamshire, UK), and
apposing membranes to X-ray ﬁlm (Kodak BioMax AR ﬁlm). All
antibodies produced a single band of expected molecular weight.
The optical densities (OD) of bands were measured using the
AlphaImager 3400, and the data expressed as OD ratios of NMDAR
subunit:b-actin.
2.6. In situ hybridization histochemistry (ISHH)
The frozen rat brain hemispheres were coronally sectioned
(14 lm) on a cryostat, and every three sections thaw-mounted
onto Superfrost-plus slides (Fisher Scientiﬁc, UK). All slides were
stored at 80 C prior to use. Slides containing sections of the
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Watson, 1986)], were pre-treated as described (Eastwood et al.,
1995). One slide from each group (‘water’, ‘FOS’ and ‘GOS’, n = 8/
group) was used for ISHH analysis.
Commercially synthesized (MWG, UK) oligodeoxyribonucleo-
tides complementary to: BDNF (bases 883–927, NM001270630.1),
NR1 (bases 746–780, NM008169.1), NR2A (bases 1642–1676,
NM008170.2) or NR2B (bases 1758–1792, NM010350.2) were used
in an establish ISHH method (Eastwood et al., 1995). Oligodeoxyri-
bonucleotide probes were 30-end labelled with [35S]-dATP using
terminal deoxynucleotidyl transferase (Promega, UK). Probes were
diluted in hybridization buffer, pipetted onto the tissue sections
(1  106 cpm/section), cover-slipped and then incubated for >16 h
at 34 C lidded Perspex trays lined with ﬁlter paper soaked with
4 SSC/50% formamide.
Post-hybridization washes included: 2 SSC rinse at room
temperature to remove cover-slips; 0.5 SSC, 20 min (3) at
55 C; 0.5 SSC 30 min (2) at room temperature. Slides were
rinsed in ddH2O, dried and apposed to X-ray ﬁlm (Kodak, Biomax
MS) for 7–28 days with 14C-microscales. Average grey densities
over the dentate gyrus, CA1, and CA3 subﬁelds of the hippocampus
in the three sections from each group were measured for each of
the mRNAs using computer-assisted image analysis, and were
calibrated to 35S nCi/g tissue equivalents using the commercial
14C-microscales and a 14C to 35S conversion factor of 3.0 (Eastwood
et al., 1995).
2.7. HPLC analysis
Small fragments of the cortical and hippocampal tissue (50 mg)
were individually homogenised in ice-cold methanol (1:10 w/v)
and centrifuged at 14,000 rpm for 10 min at 4 C. Supernatants
from faecal homogenates and plasma samples were mixed with
3 volumes of methanol and also centrifuged for 10 min at 4 C.
Supernatants (10 ll) from tissue or faecal homogenates or plasma
were subjected to online, pre-column, derivatization (Grant et al.,
2006), by injecting them onto a Hewlett–Packard 1100 liquid chro-
matography (Agilent Technologies, Palo Alto, CA), with an equal
volume of derivatizing reagent [o-phthaldialdehyde (2 mg) and
Boc-L-cysteine (2 mg) in 0.2 ml of methanol and 0.8 ml of 0.4 M
of sodium borate buffer (pH = 9)], for 5 min prior to column sepa-
ration. Separation was achieved using an Agilent Zorbax Eclipse
XDB-C18 column (4.6  150 mm, 5 lm) maintained at 30 C and
a separation protocol similar to that of (Morikawa et al., 2001).
The mobile phases consisted of acetonitrile (phase A) and
100 mM sodium acetate buffer pH = 6 (phase B) and were pumped
through the column at 1.4 ml/min. The following gradient system
was used (min/% B): 0/91, 35/84, 65/84. Detection of derivatized
amino acids was by ﬂuorescence detection (emission: 443 nm;
excitation 344 nm). Eight point calibration curves of the D- and
L-amino acids (Sigma–Aldrich, UK) were constructed using authen-
tic standards (0.5–1000 pmol) and in each case were found to be
linear with correlation coefﬁcients of >0.995.
2.8. Cell culture
The release of BDNF from human SH-SY5Y neuroblastoma cells
was investigated using a recently described protocol (Coco et al.,
2013). Brieﬂy, cells were cultured in Dulbecco’s Modiﬁed Eagle
Medium (DMEM; Sigma, Poole, UK) supplemented with 10% foetal
calf serum (Sigma), 2 mM L-glutamine (Sigma) and 1% non-essen-
tial amino acids (Sigma), maintained in a humidiﬁed incubator at
37 C and 5% CO2. Prior to release experiments, 24-well plates were
seeded with 1  105 cells/well and incubated for 24 h. Plasma
(50 ll) from rats fed water, FOS or GOS for 5 weeks (see above),
containing either IgG or anti-PYY antisera (1:200, Abnova, UK)were then added to the 0.5 ml of culture media for 4 h. A total of
24 plasma samples (8 plasmas/group) were tested in triplicate.
Some cells were incubated with synthetic PYY peptide (20 nM)
alone. This experiment was then repeated in the presence or ab-
sence of GLP-1 antisera (Millipore, UK) or GLP-1 peptide. All media
was removed following incubations, and stored at 80 C prior to
BDNF assays.
2.9. Data analysis
All data were expressed as mean ± standard error of the mean
(SEM). Statistical comparisons between groups from rat experi-
ments were performed with one-way ANOVA followed by post
hoc analysis (Tukey HSD). Cell culture data were analysed
non-parametrically (Kruskall–Wallis), followed by post hoc
Mann–Whitney U tests.
3. Results
3.1. Rat faecal Biﬁdobacteria after prebiotics
The numbers of Biﬁdobacteria in faecal pellets from FOS-fed rats
were signiﬁcantly greater than controls in an ANOVA and post hoc
(Tukey HSD) analysis i.e. controls: 2.38  109 ± 0.23  109 vs FOS:
2.98  109 ± 0.22  109, p < 0.05), whereas the numbers of Biﬁdo-
bacteria from GOS-fed animals were signiﬁcantly greater than both
controls and FOS-fed rats i.e. controls: 2.38  109 ± 0.23  109 vs
GOS: 4.28  109 ± 0.43  109, p < 0.01; and FOS: 2.98  109 ±
0.22  109 vs GOS: 4.28  109 ± 0.43  109, p < 0.05. Thus, the per-
centage increase of Biﬁdobacteria after FOS and GOS administration
relative to water intake were approximately,+25% and +80%,
respectively.
3.2. The effect of prebiotics on BDNF and NR1 in the rat frontal cortex
and hippocampus
The levels of BDNF protein in extracts of frontal cortex did not
differ between groups (Fig. 1A). However, BDNF in hippocampal
extracts of FOS administered rats were signiﬁcantly higher than
those of control and GOS fed animals. Western blots revealed that
GOS-fed rats contained signiﬁcantly greater levels of NR1 immuno-
reactivity in the frontal cortex compared to control and FOS
animals (Fig. 1B). Analysis of the hippocampus, however, revealed
that FOS rats contained signiﬁcantly more NR1 subunits than the
other groups, though an increased trend (p = 0.058) was observed
in GOS animals relative to controls.
3.3. The effect of prebiotics on NR2A and NR2B subunits in the rat
frontal cortex and hippocampus
On Western blots hippocampal, but not cortical, extracts from
GOS-fed animals, contained signiﬁcantly greater NR2A immunore-
activity compared to controls (Fig. 2). The level of NR2B in the fron-
tal cortex and hippocampus, was not affected by prebiotic feeding.
3.4. The effect of prebiotics on BDNF and NR subunit mRNAs in the
hippocampus
Prebiotic administration increased the abundance of BDNF
(Figs. 3A, C, E and 4) and NR1 (Fig. 3B, D and F) mRNAs in the den-
tate gyrus of the hippocampus, relative to controls. A reduction of
BDNF mRNA in the CA3 subﬁeld of GOS-fed rats was also observed
(Fig. 3C). Densitometry conﬁrmed signiﬁcantly greater BDNF and
NR1 expression in the dentate gyrus of prebiotic rats (Fig. 4A and
B). The administration of GOS resulted in an elevation of NR2A
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CA1 subﬁeld relative to controls and FOS-fed animals.
3.5. Faecal, plasma and brain amino acid concentrations after
prebiotics
This study tested whether an elevation of gut bacteria increased
central D-alanine concentrations by elevating the amounts of this
D-amino acid in the gut and the circulation. The concentrations of
free D-alanine in faecal pellets of GOS fed rats were signiﬁcantly
greater than control and FOS animals, with FOS administration
resulting in intermediate levels of this D-amino acid (Table 1).
Plasma D-alanine levels were signiﬁcantly higher in GOS-fed rats
compared to control animals (Table 1), and a slight, though not
signiﬁcant (p = 0.086), increase was observed in FOS-fed rats.
Prebiotic administration did not alter the concentrations of other
circulating amino acids (Table 2). Rats fed with GOS had a signiﬁ-
cantly higher concentration of D-serine in the frontal cortex com-
pared to controls (Table 2), though the levels of all other amino
acids remained unchanged after prebiotic feeding.
3.6. Body weight change, and plasma glucose, BDNF, PYY and GLP-
1after prebiotics
The administration of GOS signiﬁcantly increased the concen-
tration of plasma PYY, but neither FOS nor GOS signiﬁcantly alteredcirculating GLP-1 (Table 3). An increased trend (p = 0.077) was
noted in the plasma of FOS-fed rats. Glucose levels, body weight
and plasma BDNF were not signiﬁcantly changed after prebiotic
feeding.
3.7. Correlations
There was a signiﬁcant correlation between the number of
faecal Biﬁdobacteria and frontal cortex NR1 protein (Pearson’s
r = 0.713, p < 0.05), in a pooled analysis of control and experimen-
tal animals (n = 24). There was also an overall correlation between
microbiota numbers and plasma D-alanine (r = 0.54, p < 0.05) and
L-alanine (r = 0.52, p < 0.05). No other parameter measured in
either plasma or brain correlated with faecal Biﬁdobacteria
numbers. There was an overall signiﬁcant correlation between
the levels of cortical D-serine and NR1 protein (Pearson’s
r = 0.684, p = 0.01). Individual group analysis revealed that this
association was only signiﬁcant after GOS feeding (GOS: r = 0.96,
p = 0.04; FOS: r = 0.68, p = 0.32; water: r = 0.01, p = 0.989).
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Fig. 3. Representative autoradiographs of BDNF (A, C and E) and NR1 subunit (B, D and F) mRNA expression in the rat hippocampus following an oral administration of water
(A and B), FOS (C and D) or GOS (E and F). Arrows delineate increased expression, and arrow head indicates reduced expression. DG = dentate gyrus, CA1 and CA3 = Cornu
Ammons subﬁelds of the hippocampus. Scale bar = 200 lM.
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SY5Y cells
The addition of plasma from rats fed with GOS, elevated the
extracellular concentrations of BDNF compared to controls(Fig. 5A). These levels were similar to those from cells exposed to
synthetic PYY. A non-signiﬁcant increase of BDNF release was also
noted after the addition of FOS plasma. In the presence of PYY anti-
sera BDNF secretion by GOS plasma did not reach signiﬁcance. In
another experiment, the presence of GLP-1 antisera did not affect
Table 1
Amino acid concentrations in rat faecal pellets and plasma following a ﬁve week oral
administration of water or prebiotic.
[Amino acid] (nmol/g faeces) & (nmol/ml plasma)
Amino acid Water FOS GOS
Faecal pellets
L-Alanine 7.8 ± 0.3 12.5 ± 0.8
* 18.7 ± 1.8*,**
D-Alanine 4.2 ± 0.1 5.9 ± 0.2 9.0 ± 0.9
*,**
L/D-Alanine 1.9 ± 0.1 2.1 ± 0.1 2.1 ± 0.1
Glutamate 13.1 ± 1.2 20.9 ± 1.2 32.4 ± 3.4*,**
Glutamine 1.6 ± 0.1 2.8 ± 0.2a 4.2 ± 0.4*,**
Glut/Gln 8.0 ± 0.2 7.4 ± 0.2 7.8 ± 0.1
L-Serine 3.9 ± 0.2 7.0 ± 0.8 10.7 ± 1.1
*,**
D-Serine 0.1 ± 0.01 0.2 ± 0.01
* 0.2 ± 0.02*
L/D-Serine 39.0 ± 1.1 35.0 ± 2.5 53.5 ± 2.2
*
Plasma
L-Alanine 299.9 ± 22.1 308.6 ± 21.8 310.0 ± 21.7
D-Alanine 4.0 ± 0.5 5.2 ± 0.4 6.1 ± 0.5
*
L/D-Alanine 79.2 ± 8.8 61.7 ± 6.9 49.3 ± 1.7
*
Glutamate 82.6 ± 6.6 78.9 ± 7.3 68.7 ± 1.6
Glutamine 419.0 ± 14.1 420.9 ± 18.7 411.2 ± 17.9
Glut/Gln 0.2 ± 0.02 0.2 ± 0.01 0.2 ± 0.01
L-Serine 141.8 ± 7.8 142.9 ± 5.3 144.0 ± 6.8
D-Serine 2.0 ± 0.1 1.9 ± 0.1 2.0 ± 0.1
L/D-Serine 72.2 ± 2.4 74.5 ± 1.1 72.5 ± 1.6
* p < 0.05 compared to water.
** p < 0.05 compared to FOS.
Table 2
Amino acid concentrations in the rat cortex and hippocampus following a ﬁve week
oral administration of water or prebiotic.
[Amino acid] (pmol/mg tissue)
Amino acid Water FOS GOS
Frontal cortex
L-Alanine 90.5 ± 7.9 100.9 ± 8.4 108.6 ± 6.6
D-Alanine 2.6 ± 0.4 2.4 ± 0.2 2.3 ± 0.3
L/D-Alanine 37.7 ± 5.9 42.8 ± 3.2 42.2 ± 2.0
Glutamate 783.9 ± 75.6 837.3 ± 48.0 822.3 ± 47.9
Glutamine 618.9 ± 52.7 645.4 ± 44.7 700.5 ± 44.0
Glut/Gln 1.27 ± 0.06 1.32 ± 0.1 1.18 ± 0.03
L-Serine 141.4 ± 13.6 152.8 ± 6.0 161.8 ± 10.9
D-Serine 40.3 ± 2.9 48.7 ± 1.7 53.6 ± 3.4
*
L/D-Serine 3.5 ± 0.23 3.1 ± 0.07 3.0 ± 0.14
Hippocampus
L-Alanine 99.7 ± 9.5 92.0 ± 6.2 97.5 ± 9.3
D-Alanine 2.8 ± 0.4 2.6 ± 0.2 2.3 ± 0.2
L/D-Alanine 36.9 ± 3.9 36.5 ± 3.7 42.0 ± 2.5
Glutamate 705 ± 79.8 649 ± 59.3 643.9 ± 68.1
Glutamine 545.1 ± 58.2 480.1 ± 52.6 504.6 ± 48.0
Glut/Gln 1.30 ± 0.04 1.38 ± 0.09 1.27 ± 0.05
L-Serine 121.4 ± 12.4 111.4 ± 7.8 111.9 ± 9.3
D-Serine 37.4 ± 4.1 34.6 ± 2.1 35.3 ± 3.4
L/D-Serine 3.3 ± 0.03 3.2 ± 0.04 3.2 ± 0.08
* p < 0.05 compared to water.
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signiﬁcant reduction of BDNF release after the addition of FOS plas-
ma was noted.
4. Discussion
Studies have shown that probiotics have psychotropic effects,
but the neurobiological consequences of prebiotic intake have
not been explored. The aim of the current study was to provideunequivocal evidence for neurochemical and molecular changes
in the rat brain following prebiotic consumption, to prelude future
functional analyses. The speciﬁc hypotheses tested were, ﬁrst, that
Biﬁdobacteria proliferation by prebiotics is associated with an in-
crease in brain BDNF, as evinced with probiotics; and second, that
prebiotic augmentation of commensal microbiota elevates central
NMDAR subunits, given that these receptors are reduced in
germ-free rodents. Our data support both suppositions and present
substantial grounds for exploring the utility of prebiotics in the
modulation of brain function. We have also offered an initial
indication for the involvement of PYY, and potentially other gut
hormones, in the augmentation of BDNF signalling following prebi-
otic intake. The interpretations and relevance of our ﬁndings are
discussed in turn.
The elevated expression of BDNF and encoded protein in rats
fed with FOS, is consistent with the effect of a Biﬁdobacterium pro-
biotic (Bercik et al., 2011a; O’Sullivan et al., 2011) and the selective
proliferation of these species with antimicrobials (Bercik et al.,
2011a). Thus, FOS administration may have augmented the coloni-
zation of similar psychotropic strains, within the moderate overall
increase in Biﬁdobacteria numbers relative to GOS fed rats. In view
of these observations therefore, it was surprising that GOS did not
alter the levels of hippocampal BDNF protein and, moreover, by a
greater magnitude than FOS.
Unaltered BDNF protein after GOS feeding may have reﬂected
the reciprocal change in BDNF mRNA in the dentate gyrus and
CA3 region of the hippocampus. If these alterations were translated
to protein, then it is unlikely that an overall change in BDNF would
be detected in whole hippocampal homogenates. The measure of
BDNF in regionally dissected hippocampus would test this possibil-
ity. Arguing against a causal link between gut bacterial densities
and BDNF gene expression, is a similar increase of BDNF mRNA
in the dentate gyrus of both FOS and GOS rats, in spite of the fewer
numbers of Biﬁdobacteria in the FOS group. The possibility that pre-
biotics alter brain signalling independently of the gut microbiota
cannot be ruled out, and a direct interaction between oligosaccha-
rides and the gut mucosa has been shown to inﬂuence the response
of the immune system (Bode et al., 2004; Eiwegger et al., 2010),
which may then impact on brain chemistry. The elevation of gut
hormones after prebiotic intake might also reﬂect a direct effect
of oligosaccharides on the gut (see below).
The physiological relevance of a reciprocal change in BDNF
mRNA in two regions of the hippocampus after GOS intake is
difﬁcult to interpret without functional measures. However, an
elevation of BDNF gene expression in the dentate gyrus has been
associated with antidepressant action (Kerman, 2012). A similar
elevation of BDNF mRNA after FOS and GOS administration is,
therefore, in keeping with a potential antidepressant/anxiolytic
property of gut bacteria (Bercik et al., 2011a). The concomitant de-
crease of BDNF mRNA in the CA3 is more difﬁcult to interpret,
though one possibility is that we were observing the differential,
activity-dependent expression of BDNF mRNA splice variants in
each hippocampal subﬁeld (Chiaruttini et al., 2008). Regional
molecular and electrophysiological analyses of the rat hippocam-
pus after GOS administration are, therefore, required.
The potential mechanisms underlying the elevation of cortical
NR1 subunits after GOS feeding remains elusive, and although they
correlate with Biﬁdobacteria numbers (see Section 3), elevated NR1
may have also been mediated by the direct physiological response
of the gut to GOS such as the release of PYY (see discussion below).
Nevertheless, the signiﬁcant elevation of hippocampal NR1 mRNA
after FOS and GOS administration is intuitive in view of data
showing reduced NR1 in mice devoid of gut bacteria (Neufeld
et al., 2011), though it is not clear why a parallel change in
hippocampal NR1 protein occurred only after FOS feeding. Given
the potential complexities of prebiotic actions already encountered
Table 3
Rat body weight change (D), plasma glucose, BDNF, GLP-1 and PYY levels after a
5 week oral administration of water, FOS or GOS.
Group
Parameter Water FOS GOS
DBody weight (g) 85.7 ± 4.3 86.6 ± 4.5 79.0 ± 5.0
Plasma
BDNF (ng/L) 32.4 ± 6.5 29.0 ± 5.2 30.4 ± 6.2
Glucose (mM) 7.3 ± 0.4 6.9 ± 0.4 7.7 ± 0.3
GLP-1 (ng/L) 201.7 ± 24.1 258.1 ± 26.2 199.4 ± 27.9
PYY (ng/L) 90.7 ± 8.4 94.9 ± 11.8 134.4 ± 12.0*
* p < 0.05 compared to water.
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hippocampus), unaltered hippocampal NR1 protein in GOS rats
may be authentic, and mechanistically associated with the increase
of NR2A subunits, which was not apparent after FOS intake. Altered
NR1:NR2 subunit ratios in the rodent hippocampus following
pharmacological and genetic manipulations are not unusual
(Owczarek et al., 2011; Kato et al., 2012), and in the latter study,
an increase of NR2A, but not NR1, subunits is associated with sig-
niﬁcant functional outcomes. Similarly, unaltered NR2B subunits
after prebiotic administration may suggest that Biﬁdobacteria
and/or the metabolic response to GOS ingestion may not affect
the neurophysiological processes, such as long-term depression,
which are associated with dynamic changes in NR2B subunits
(Liu et al., 2004). Of course, the lack of functional information to
support our interpretations of these data is the major caveat of this
study.
The demonstration of elevated faecal and plasma D-alanine
concentrations after GOS feeding is consistent with studies show-
ing that gut bacteria, including Biﬁdobacteria, are a source of this(A)
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Fig. 5. The effect of prebiotic-fed rat plasmas on BDNF release from SH-SY5Y cells, in th
exposed to plasma from water-fed rats; #p < 0.001, compared to cells exposed to plasma
exposed to plasma from water-fed rats containing PYY or GLP-1 peptide (n = 8 plasmasD-amino acid (Konno et al., 1993). The signiﬁcant reduction of
blood L/D-alanine ratios conﬁrms that this D-alanine was not di-
rectly derived from circulating L-alanine. In spite of this, central
D-alanine concentrations remained unaltered after prebiotic feed-
ing, and this may be because, higher plasma concentrations are re-
quired to initiate the appropriate kinetics for D-alanine uptake into
the brain (Morikawa et al., 2007).
The current investigation also revealed that GOS-fed rats con-
tained greater amounts of cortical D-serine than controls. Since
the same animals also showed greater levels of cortical NR1
subunits which are the D-serine binding moiety, it is reasonable
to propose that NMDAR mediated signalling was elevated in the
frontal cortex. Of course, only direct electrophysiological analysis
of NMDAR signalling after GOS feeding can prove this. Of note,
the increase of cortical D-serine did not appear to arise from the
plasma but may have been synthesized locally, as suggested by a
slight, though not signiﬁcant, rise of cortical L-serine after GOS
feeding. That is, the synthesis of D-serine from L-serine by serine
racemase (Sikka et al., 2010), may have been a homeostatic re-
sponse (preservation of L/D-serine ratios) to either local elevations
of the L-enantiomer, and/or a greater demand for D-serine. The
possibility that D-alanine is linked to an elevation of central
D-serine signalling, is suggested by studies demonstrating aug-
mented D-serine release from neurons in the presence of D-alanine
(Rosenberg et al., 2010).
We have conﬁrmed that the administration of GOS to rats in-
creases circulating concentrations of PYY (Overduin et al., 2013).
It is reasonable to suggest, therefore, that the effects of GOS on
brain signalling may be mediated by gut hormones. Earlier work
has shown that PYY has the potential to affect the brain either
directly (Connor et al., 1997; Nonaka et al., 2003) or via vagal nerve
activity (Hernandez et al., 1994). Our in vitro data suggest thatwater+PYY
d
Plasma
Plasma+PYYab
* #
+
water +
Plasma
Plasma+GLP-1ab
* #
GLP-1
+
e absence or presence of PYY (A) or GLP-1 (B) antisera. ⁄p < 0.05, compared to cells
from water-fed rats containing PYY or GLP-1 antisera; +p < 0.05, compared to cells
/group).
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mediated by plasma PYY. Another study has shown that plasma
from mice administered with Biﬁdobacterium longum, did not
change the expression of BDNF mRNA in cultured SH-SY5Y cells
(Bercik et al., 2011b), and this was reasoned to be further evidence
of a vagal, rather than a ‘blood-borne’ mediation of probiotic
central effects. It is reasonable to assume that our discrepant data
reﬂect the different parameters measured in both studies (i.e.
BDNF release versus gene expression) and/or different actions of
B. longum and prebiotics on brain BDNF. However, the presence
of neuroactive substances in blood does not preclude the involve-
ment of gut-brain vagal circuitry after prebiotic ingestion. The
enteric secretion of PYY after GOS intake may directly affect local
BDNF signalling in myenteric neurons of the gut (Boesmans
et al., 2008), which innately inﬂuence vagal nerve activity (Murphy
and Fox, 2010). Of course, since circulating PYY can also directly
access brain PYY receptors (Hernandez et al., 1994; Nonaka et al.,
2003), in all likelihood, the central effects of PYY would involve
direct and indirect mechanisms. However, the mechanisms under-
lying the increase of hippocampal BDNF after FOS intake remain
elusive. Whether PYY or, indeed, other factors such as short-chain
fatty acids (Jakobsdottir et al., 2013), and/or the immune system
(Vulevic et al., 2008, 2013), underlie the changes in BDNF and
NMDAR signalling after prebiotics, requires further examination.5. Conclusion
Our results have provided the necessary ‘proof-of-principle’ for
the central actions of prebiotic consumption. The increase of hip-
pocampal BDNF after prebiotic intake is consistent with a probiotic
effect, and may have been a direct consequence of elevated gut
Biﬁdobacteria numbers. However, an additional effect of gut hor-
mones (e.g. PYY) or other mediators, such as the immune system
resulting from direct oligosaccharide-gut interactions, cannot be
ruled out. The elevation of NMDAR subunits after prebiotics is
intuitive given their reduction in the brains of germ-free animals.
Furthermore, the strong correlation between Biﬁdobacteria num-
bers and cortical NR1 levels presented in this report, further sup-
ports a link between the microbiota and central glutamate
neurotransmission. Mechanistic investigations beyond the scope
of the present study, are now required to ascertain the systems
underlying the observed changes, and will also reveal if vagal nerve
modulation is involved. Moreover, behavioural analysis in rats will
ascertain if the changes in BDNF after prebiotics impart an
anxiolytic action, or that increased NMDAR subunits translate to
improved cognitive performance. Importantly, our study has
provided sufﬁcient cause to warrant further exploration into the
utility of prebiotics in therapies of neuropsychiatric illness and
which, by virtue of their ability to proliferate gut bacteria and stim-
ulate neuroendocrine (and other) responses, may even prove to be
more potent than probiotics.Conﬂict of interest
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